Skip to ContentSkip to Navigation
founded in 1614  -  top 100 university
About us Practical matters How to find us prof. dr. H.J. (Hiddo) Lambers Heerspink
University Medical Center Groningen

prof. dr. H.J. (Hiddo) Lambers Heerspink

Clinical Pharmacologist
Profile picture of prof. dr. H.J. (Hiddo) Lambers Heerspink
Telephone:
E-mail:
h.j.lambers.heerspink umcg.nl

Publications

A meta-analysis of albuminuria as a surrogate endpoint for kidney failure

Effects of Dapagliflozin on Health-Related Quality of Life in Patients with CKD

Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis

Efficacy and Safety of Baxdrostat in Participants with CKD and Uncontrolled Hypertension: A Randomized, Double-Blind, Placebo-Controlled Trial

Indexing for Body Surface Area when Assessing Kidney Function

Mechanisms of SGLT inhibitor action and physiological mediators: systematic review and protocol for the MOSAIC collaborative meta-analysis

Proteins and signalling pathways targeted by dapagliflozin and finerenone: Insights from DAPA-CKD and FIGARO-DKD

SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis

Strategies for the development of sodium-glucose cotransporter-2 inhibitors for kidney protection in pediatric chronic kidney disease: proceedings of a workshop meeting in July 2023

Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial

Press/media

The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum

Nonsteroidal MRA & SGLT2i in People With CKD & T2D: Current Evidence and Rationale for Combination Therapy

Finerenone Improves UACR in T1D, CKD

'Nieuw' medicijn vermindert nierschade bij diabetespatiënten

Bayer Aktie: Neue Finanzchefin und Studienerfolg

Kidney drug trial raises hopes for new type 1 diabetes treatment

Hoe afslankmedicijnen het hele lichaam veranderen: ‘Mijn hoofd roept niet meer om eten’

智康弘义宣布SC0062临床II期糖尿病肾病队列研究达到12周主要终点 | 项目进展

Diabetesmedicijn Ozempic heeft ook positief effect bij chronische nierschade